Steve Nissen Articles
Lepodisiran: What progress towards Lp(a) reduction?
Lepodisiran (LY3819469) is a short interfering RNA (siRNA) targeted at the mRNA for apolipoprotein A (apoA) – an essential component of lipoprotein a (Lp(a)). Elevated levels of Lp(a) are associated with atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis, and Lp(a) measurement is recommended at least…
read more »
Bempedoic acid: A CLEAR story
Reports from the 19th Virtual Closed Scientific Expert Meeting of the Editorial Board Steven Nissen
read more »Posted on 19 October 2023 |
Posted by Steve Nissen | Posted in Closed Scientific Expert Meetings of the Editorial Board,
19th Closed Scientific Expert Meeting of the Editorial Board
siRNA-mediated lowering of Lp(a) by SLN360
Reports from the 17th Virtual Closed Scientific Expert Meeting of the Editorial Board Steve Nissen
read more »Posted on 16 December 2022 |
Posted by Steve Nissen | Posted in Hot topics,
17th Closed Scientific Expert Meeting of the Editorial Board
